Results 91 to 100 of about 51,637 (256)
Mycophenolate mofetil for myasthenia gravis: An open-label pilot study [PDF]
, 2001 Emma Ciafaloni +3 more
openalex +1 more source
The Case of a Glucocorticoid-Induced Myopathy & Myasthenia Gravis Combination: Is There a Border? [PDF]
, 2021 Irina Dzherieva +7 more
openalex +1 more source
Chronic Rhinosinusitis and Autoimmune Diseases: A Comprehensive Large Population‐Based Analysis
Laryngoscope Investigative Otolaryngology, Volume 11, Issue 1, February 2026.ABSTRACT Objectives To evaluate associations between a wide variety of autoimmune diseases and chronic rhinosinusitis without nasal polyposis (CRSsNP), CRS with nasal polyposis (CRSwNP), and the need for endoscopic sinus surgery. Methods This is a multicenter retrospective study from January 1, 2010 to July 31, 2025 utilizing data from 106 healthcare ...
Robert E. Africa +3 more
wiley +1 more source
Successful use of sugammadex for caesarean section in a patient with myasthenia gravis
Revista Brasileira de AnestesiologiaMyasthenia gravis is an autoimmune disorder that is characterized by muscle weakness that fluctuates, worsening with exertion, and improving with rest. Diagnosis of myasthenia gravis is made following clinical and physical examination and is confirmed by
Lokman Soyoral +3 more
doaj +1 more source
Muscle &Nerve, Volume 73, Issue 2, Page 297-303, February 2026.ABSTRACT Introduction/Aims A pragmatic evaluation of bulbar function among adults with spinal muscular atrophy (awSMA) is needed, requiring the validation of a low‐cost, feasible outcome measure (OM). Maximum phonation time (MPT) and S/Z ratio (S/Z) are potential low‐cost OMs for bulbar function. This study aimed to evaluate the psychometric properties
Jeremy Slayter +5 more
wiley +1 more source
Development of myasthenia gravis in two patients with multiple sclerosis following interferon treatment [PDF]
, 2004 J Dionisiotis
openalex +1 more source
The Journal of Pathology, Volume 268, Issue 2, Page 135-149, February 2026.Abstract Type B1 and B2 thymomas are lymphocyte‐rich malignant tumours with few somatic mutations in protein‐coding regions of the nuclear genome; nonetheless, noncoding regions remain uncharacterized. Here, we developed a method to isolate pure thymoma cells from lymphocyte‐rich tissues, and then performed genome‐wide deep sequencing. The total number
Kohei Fujikura +10 more
wiley +1 more source
Research advancement in immunopathogenesis of myasthenia gravis [PDF]
, 2010 Sha Huang, Liming Tan
openalex +1 more source
Impact of COVID-19 in AChR Myasthenia Gravis and the Safety of Vaccines: Data from an Italian Cohort [PDF]
, 2022 Antonino Lupica +7 more
openalex +1 more source
Exploring Pembrolizumab‐Induced IM3OS in a Patient With Bladder Cancer
Pharmacology Research &Perspectives, Volume 14, Issue 1, February 2026.ABSTRACT Pembrolizumab, an immune checkpoint inhibitor (ICI), has transformed cancer treatment across various malignancies, including metastatic urothelial cancer. As the use of pembrolizumab becomes increasingly widespread, understanding its potential adverse effects is essential.
Ching‐Cheng Chan +3 more
wiley +1 more source